Going Beyond Topical Steroids and Calcineurin Inhibitors for AD Treatment

The panel examines the evolution of atopic dermatitis (AD) treatment beyond topical steroids and calcineurin inhibitors, while evaluating the safety and efficacy of a specific topical therapy in AD management.

EP: 1.Tackling Key Concerns in Atopic Dermatitis + Biologic Use

EP: 2.Atopic Dermatitis: Topical Therapies and Unmet Needs in the Treatment Landscape

Now Viewing

EP: 3.Going Beyond Topical Steroids and Calcineurin Inhibitors for AD Treatment

EP: 4.Experts Discuss Long-Term Effects and Monitoring in AD Therapy

1. Based on your experience, how have topical treatments evolved beyond the use of topical steroids and topical calcineurin inhibitors?
2. When it comes to topical ruxolitinib, how do you balance the efficacy versus the safety when deciding to treat patients with it?

Related Videos

Related Content

Advertisement

July 3rd 2024

Study Finds Link Between Vitamin D Levels at Start of Immunotherapy and Overall Survival

Mary Caffrey

Researchers from the University of Manchester sought to understand whether the season of administration of immunotherapy affected outcomes.

May 30th 2024

From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care

Giuliana Grossi

In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.

July 3rd 2024

Cancer Drug Shortage: Causes, Trends, and Implications for Clinical Trials

Pearl Steinzor

Crystal S. Denlinger, MD, FACP, CEO of the National Comprehensive Cancer Network, breaks down the causes of the ongoing cancer drug shortage, as well as its impact on clinical trials.

May 9th 2024

Frameworks for Advancing Health Equity: Urban Health Outreach

Giuliana Grossi

In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.

July 2nd 2024

Study Finds Ravulizumab Effective in Treating Acetylcholine Receptor–Positive Generalized MG

Karen Jacobson-Sive

More than 60% of complement inhibitor–naive patients with acetylcholine receptor–positive generalized myasthenia gravis (MG) in diverse clinical populations had a clinically meaningful reduction in MG activities of daily living scores.

July 2nd 2024

Minority Patients With Gynecologic Cancers More Likely to Receive Treatment at Academic Facilities

Brooke McCormick

Minority patients with gynecologic cancers are more likely than White patients to receive treatment at academic facilities, a recent study found.

Related Content

Advertisement

July 3rd 2024

Study Finds Link Between Vitamin D Levels at Start of Immunotherapy and Overall Survival

Mary Caffrey

Researchers from the University of Manchester sought to understand whether the season of administration of immunotherapy affected outcomes.

May 30th 2024

From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care

Giuliana Grossi

In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.

July 3rd 2024

Cancer Drug Shortage: Causes, Trends, and Implications for Clinical Trials

Pearl Steinzor

Crystal S. Denlinger, MD, FACP, CEO of the National Comprehensive Cancer Network, breaks down the causes of the ongoing cancer drug shortage, as well as its impact on clinical trials.

May 9th 2024

Frameworks for Advancing Health Equity: Urban Health Outreach

Giuliana Grossi

In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.

July 2nd 2024

Study Finds Ravulizumab Effective in Treating Acetylcholine Receptor–Positive Generalized MG

Karen Jacobson-Sive

More than 60% of complement inhibitor–naive patients with acetylcholine receptor–positive generalized myasthenia gravis (MG) in diverse clinical populations had a clinically meaningful reduction in MG activities of daily living scores.

July 2nd 2024

Minority Patients With Gynecologic Cancers More Likely to Receive Treatment at Academic Facilities

Brooke McCormick

Minority patients with gynecologic cancers are more likely than White patients to receive treatment at academic facilities, a recent study found.